TO THE LICENSE AND RESEARCH COLLABORATION AGREEMENTSupplemental Agreement • May 24th, 2016 • Selecta Biosciences Inc • Pharmaceutical preparations
Contract Type FiledMay 24th, 2016 Company IndustryThis Supplemental Agreement No. 1 (“Supplement No. 1”) to the License and Research Collaboration Agreement dated November 27, 2012 (the “License Agreement”) is entered into as of May 7, 2015 (the “Supplement Effective Date”) by and between SELECTA BIOSCIENCES, INC. (“Selecta”), and SANOFI (“Sanofi”). Selecta and Sanofi shall be individually referred to as a “Party” and collectively as the “Parties.”
TO THE LICENSE AND RESEARCH COLLABORATION AGREEMENTSupplemental Agreement • March 18th, 2016 • Selecta Biosciences Inc • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2016 Company IndustryThis Supplemental Agreement No. 1 (“Supplement No. 1”) to the License and Research Collaboration Agreement dated November 27, 2012 (the “License Agreement”) is entered into as of May 7, 2015 (the “Supplement Effective Date”) by and between SELECTA BIOSCIENCES, INC. (“Selecta”), and SANOFI (“Sanofi”). Selecta and Sanofi shall be individually referred to as a “Party” and collectively as the “Parties.”